The first in the country!

On April 14, Kelun Pharmaceutical issued two consecutive announcements, the company's medium and long chain fat emulsion/amino acid (16)/glucose (36%) injection and medium and long chain fat emulsion/amino acid (16)/glucose (30 %) The injection was approved on the same day as the imitation Category 3, which is regarded as over-evaluation.

The data show that medium and long chain fat emulsion/amino acid (16)/glucose (36%) injection and medium and long chain fat emulsion/amino acid (16)/glucose (30%) injection are parenteral nutrition treatments developed by Braun, Germany.

Competition Landscape of Medium and Long Chain Fat Emulsion/Amino Acid (16)/Glucose (36%) Injection

Source: One-click retrieval from Minet

Medium- and long-chain fat emulsion/amino acid (16)/glucose (36%) injection is the first domestically approved three-chamber bag for small-scale parenteral nutrition.

Competition Landscape of Medium and Long Chain Fat Emulsion/Amino Acid (16)/Glucose (30%) Injection

Source: One-click retrieval from Minet

The medium and long chain fat emulsion contained in the formula of medium and long chain fat emulsion/amino acid (16)/glucose (30%) injection is the most widely used fat emulsion recommended by domestic and foreign guidelines, because energy supply does not depend on liver carnitine , good liver tolerance, especially suitable for patients with impaired liver function

Kelun's approved new parenteral nutrition products

Source: Company announcements

At present, Kelun Pharmaceutical has 14 new parenteral nutrition products, covering single-bag, double-chamber bag, and three-chamber bag packaging.

According to the data of Minet.